No More

Cellulite Nonsense

Introducing AvéliTM – the long-term solution setting a new standard in cellulite.1

About AvéliTM

No More

Silence

Up To

90%

of women have cellulite yet nearly no one talks about it.2
Why are we whispering?

Why are we whispering? Let the cellulite conversation commence.

We are a community of women and physicians taking cellulite seriously and treating it like the real medical condition it is.

No more stigma. No more shame. No more nonsense.

Let’s Talk Cellulite

Hear Jamie's

Cellulite
Story

Introducing AveliTM

Setting a new standard in cellulite.
It’s time to expect more. Avéli™ is a device used during a minimally invasive procedure performed with local anesthesia by a trained provider. Women see a long-term reduction in the appearance of cellulite dimples quickly after a single in-office procedure.1,3
Avéli_034011_Before Avéli_034011_After1Year
  • Long-term cellulite reduction1
  • Minimally invasive procedure3
  • Single in-office visit3
  • Meaningful results visible quickly4

Photos not retouched. After photo taken 1 year post-procedure. Individual results will vary.

See More Results

Avéli™ is indicated for long-term reduction in the appearance of cellulite in the buttocks and thigh areas of adult females as supported by clinical data demonstrating treatment benefits through one year of observation. The most common side effects reported were mild pain within the first 24 hours and bruising and tenderness to the touch which typically resolved within 30 days. Some patients returned to normal activities within one day of the procedure and most within a week. As with any medical procedure, there are risks associated with the procedure. Consult with your physician for full safety information.

References:

  1. Stevens WG, Green JB, Layt C, et al. Multicenter Pivotal Study Demonstrates Safety and Efficacy of a New Cellulite Procedure: Final Results at 12 Months [published online ahead of print, 2022 Nov 10]. Aesthet Surg J. 2022;sjac291
  2. Emanuele E. Cellulite: advances in treatment: facts and controversies. Clin Dermatol. 2013;31(6):725-30.
  3. Stevens WG, Kaminer MS, Fabi SG, Fan L. Study of a New Controlled Focal Septa Release Cellulite Reduction Method. Aesthet Surg J. 2022;42(8):937-945. 
  4. Stevens WG, Green JB, Layt C, et al. Multicenter Pivotal Study Demonstrates Safety and Efficacy of a New Cellulite Procedure: 3-Month Results [published online ahead of print, 2022 Jul 5]. Aesthet Surg J. 2022 Jul 5;sjac179. doi:10.1093/asj/sjac179.
This website uses cookies and other technologies to personalize content and to show you more personalized ads (for example, Google Ads and Facebook) on this and other websites, as well as provide you with social media features on this website (such as, Facebook, Twitter, LinkedIn).
Read More
By clicking “Accept” you understand that you are directing Revelle Aesthetics to disclose your personal information, including internet tracking data (like cookies and the IP address you used to access this website), to these third parties for the purposes stated above. You can still use this website if you do not click “Accept,” but your experience may be different. For more information, including a list of the categories of third parties to whom we disclose your personal information, please refer to our Privacy Policy or for additional options please check your browser’s settings.
Accept All Cookies
Cookies Settings